MicroRNA-126 selected with broad-spectrum analysis of microRNAs – a new predictive factor for the effectiveness of immunotherapy or chemoimmunotherapy in advanced NSCLC patients?

Overview of attention for article published in Frontiers in immunology, February 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 33,708 followers.

RT @FrontImmunol: New Research: MicroRNA-126 selected with broad-spectrum analysis of microRNAs – a new predictive factor for the effective…

RT @FrontImmunol: New Research: MicroRNA-126 selected with broad-spectrum analysis of microRNAs – a new predictive factor for the effective…

RT @FrontImmunol: New Research: MicroRNA-126 selected with broad-spectrum analysis of microRNAs – a new predictive factor for the effective…

RT @FrontImmunol: New Research: MicroRNA-126 selected with broad-spectrum analysis of microRNAs – a new predictive factor for the effective…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.